Credit Suisse Maintains Outperform on Tenet Healthcare, Raises Price Target to $98
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst A.J. Rice has maintained an Outperform rating on Tenet Healthcare (NYSE:THC) and raised the price target from $92 to $98.
August 04, 2023 | 11:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Credit Suisse has maintained an Outperform rating on Tenet Healthcare and raised the price target from $92 to $98, which could lead to a positive market reaction.
The raised price target by Credit Suisse indicates a positive outlook for Tenet Healthcare. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100